He Sudan | Molecular Biology | Best Researcher Award

Published on by Best Achievements

Prof. Dr. He Sudan | Molecular Biology | Best Researcher Award

Prof. Dr. He Sudan | Suzhou Institute of Systems Medicine | China

Prof. Dr. Sudan He is a Professor and Deputy Director at the Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College. She earned her Ph.D. from Peking Union Medical College and trained under Prof. Xiaodong Wang. Renowned for her pioneering work on necroptosis and regulated cell death, she has published 46 SCI-indexed papers, received over 6,200 citations, holds three patents, and serves on multiple editorial boards, making her a highly influential researcher in her field.

Profiles

Scopus 
Orcid

Early Academic Pursuits

Dr. Sudan He began her academic journey with a strong foundation in biomedical sciences, earning her Ph.D. from Peking Union Medical College. She honed her expertise in cell biology and immunology during her postdoctoral training in the laboratory of Professor Xiaodong Wang at the National Institute of Biological Sciences, Beijing. These early academic experiences shaped her research trajectory in regulated cell death and provided her with advanced scientific training that later enabled her to establish an independent research group at Soochow University.

Professional Endeavors

Dr. He has held several significant academic and leadership roles throughout her career. After joining Soochow University as a faculty member, she later relocated to the Suzhou Institute of Systems Medicine, where she built a thriving research program. In recognition of her contributions, she was appointed Deputy Director of the institute in 2023. She has also engaged extensively with industry-sponsored projects and served in editorial positions for reputed journals, contributing to the advancement of scientific publishing in her field.

Contributions and Research Focus

Dr. He’s research focuses on molecular mechanisms of regulated cell death, particularly necroptosis. Her pioneering work identified the essential role of RIP3 (RIPK3) in necroptosis and discovered the TLR3/4–TRIF–RIP3 axis as a key pathway in cell death. She further uncovered the ICP6-RIPK3 interaction as a host defense mechanism against viral infections. Recently, her group revealed the role of the RIP1-RIP3 complex in GVHD-associated inflammation, which opened avenues for novel therapeutic strategies now being tested in clinical trials.

Impact and Influence

Dr. He’s work has had a profound impact on both basic and translational research in cell death biology. Her discoveries have been published in prestigious journals such as Cell, PNAS, Nature Communications, Blood, Leukemia, and the Journal of Cell Biology. Her publications have received over 6,218 citations, reflecting her influence within the global research community. She has also contributed to drug discovery projects, particularly the identification of necroptosis inhibitors, thereby bridging the gap between fundamental biology and clinical applications.

Research Skills

Dr. He has demonstrated exceptional research skills in dissecting molecular signaling pathways, utilizing advanced cell biology techniques, and translating findings into clinical applications. Her expertise spans genetic manipulation, cell death assays, molecular imaging, and therapeutic target validation. She is equally adept at collaborative research, having worked with international and national partners, and at leading multidisciplinary teams to achieve groundbreaking outcomes. Her ability to integrate basic science with translational goals underscores her versatility as a researcher.

Awards and Honors

Dr. He has been recognized as an Elsevier Highly Cited Chinese Researcher, a testament to her research excellence and influence. She has successfully secured multiple national and industry-funded projects with a combined funding of around 3 million RMB. She has also received acknowledgment through editorial board appointments for journals like Cell Death and Disease and Frontiers in Cell Death, reflecting the academic community’s trust in her expertise.

Legacy and Future Contributions

Dr. He’s legacy lies in her trailblazing discoveries in necroptosis research, which have shaped current understanding of regulated cell death and its role in disease pathogenesis. Moving forward, she aims to expand her research into therapeutic applications, particularly in autoimmune diseases, inflammation, and oncology. Her ongoing clinical collaborations and translational projects suggest a promising future where her discoveries will directly influence patient care and therapeutic innovations.

Publications Top Notes

Harnessing ZIKV NS2A RNA for alleviating acute hepatitis and cytokine release storm by targeting translation machinery

Hepatology, 2025

Authors: Sudan Dan He, et al.

Citations: 1

Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia

Leukemia, 2025

Authors: Sudan Dan He, et al.

Citations: 2

Inhibition of lysosome-tethered Ragulator-Rag-3D complex restricts the replication of Enterovirus 71 and Coxsackie A16

Journal of Cell Biology, 2023 (Open Access)

Authors: Sudan Dan He, et al.

Citations: 7

Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors

European Journal of Medicinal Chemistry, 2023

Authors: Sudan Dan He, et al.

Citations: 4

Design, synthesis, evaluation and optimization of potent IRAK4 inhibitors alleviating production of inflammatory cytokines in LPS-induced SIRS model

Bioorganic Chemistry, 2023

Authors: Sudan Dan He, et al.

Citations: 5

Conclusion

Dr. Sudan He is an accomplished researcher whose pioneering work on regulated cell death and necroptosis has significantly advanced biomedical science. With over 6,218 citations, 46 SCI publications, and recognition as an Elsevier Highly Cited Chinese Researcher, her contributions bridge fundamental discoveries and clinical applications. As a Professor and Deputy Director, she has demonstrated exceptional leadership, innovation, and collaboration. Her ongoing projects and translational research ensure she will continue to make lasting impacts on therapeutics and global health.

Zian Yi | Molecular Biology | Best Researcher Award

Published on by Best Achievements

Mr. Zian Yi | Molecular Biology | Best Researcher Award

Mr. Zian Yi, Air Force Medical University, China.

🧬 Mr. Zian Yi is a Master’s student at Air Force Medical University, specializing in Orthodontics with a research focus on osteogenic differentiation of stem cells. 🦷 He has published 4 SCI-indexed papers, 5 Chinese-language papers, and holds 7 invention patents 🇨🇳. His pioneering work on Atoh8 gene regulation enhances bone regeneration using ADSCs, advancing bone tissue engineering. 🧠🔬 Zian’s dedication to innovation and scientific discovery marks him as a rising star in regenerative medicine. 🌟📚

Profile

SCOPUS ID

🎓 Early Academic Pursuits

Mr. Zian Yi began a promising academic journey with a focus on dental sciences, ultimately pursuing a master’s degree in Orthodontics at the Air Force Medical University, China. With a deep-rooted interest in regenerative medicine, Zian concentrated early research on the osteogenic differentiation of stem cells, laying the foundation for a career in cutting-edge oral and cranio-maxillofacial therapies.

💼 Professional Endeavors

As a graduate researcher, Zian Yi has been actively involved in three major research projects, including two consultancy collaborations with industry partners. His hands-on experience in laboratory settings and clinical environments exemplifies a well-rounded professional profile within the field of orthodontic biomedical research.

🔬 Contributions and Research Focus On Molecular Biology

Mr. Zian Yi’s pivotal research explores how silencing the gene Atoh8 significantly enhances the osteogenic differentiation of adipose-derived stem cells (ADSCs). His work not only elucidates a genetic regulatory pathway but also offers a novel therapeutic approach for bone regeneration, especially relevant for cranio-maxillofacial surgery. In vivo studies have validated the effectiveness of Atoh8-knockdown ADSC sheets in promoting bone repair in animal models.

🌍 Impact and Influence

With four SCI-indexed publications, five Chinese-language papers, and seven patents, Zian Yi’s contributions are both innovative and impactful. His research has opened new avenues in bone tissue engineering and stem cell therapy, providing significant value to the scientific community and potential clinical applications.

🧠 Research Skills

Zian exhibits expertise in molecular biology techniques, gene silencing (siRNA), stem cell culture, in vivo animal modeling, and tissue engineering. His ability to translate molecular findings into pre-clinical applications underlines his comprehensive research skill set.

🏅 Awards and Honors

Zian Yi is a strong contender for the Best Researcher Award in recognition of his scientific achievements, patents, and original research contributions in stem cell-based orthodontic therapies. His work embodies both academic rigor and translational potential.

🏛️ Legacy and Future Contributions

Zian Yi aspires to lead transformative research in genetically modulated regenerative therapies, especially for maxillofacial anomalies. His future work aims to integrate gene editing, bioprinting, and biomaterials for personalized bone repair. With a foundation built on scientific integrity and innovation, Zian Yi is set to become a visionary in orthodontic regenerative medicine.

Publications Top Notes

📄 Title: Initial seizure episodes risk factors identification during hospitalization of ICU patients: A retrospective analysis of the eICU collaborative research database
👨‍🔬 Authors: N. Cheng, Zian Yi, Jiayue Wang, Jun Chen, An Gao
📰 Journal: Journal of Clinical Neuroscience
📅 Year: 2025

Yanmiao Ma | Molecular Biology | Best Researcher Award

Published on by Best Achievements

Assoc. Prof. Dr. Yanmiao Ma | Molecular Biology | Best Researcher Award

Assoc. Prof. Dr. Yanmiao Ma, Shanxi University of Traditional Chinese Medicine, China.

🔬 Dr. Yanmiao Ma is a distinguished researcher specializing in biomedical engineering and materials science. With a strong focus on nanomaterials 🧪 and drug delivery systems 💊, Dr. Ma has contributed significantly to biomedical advancements. His  has authored numerous high-impact publications 📖 and received prestigious research awards 🏆. Passionate about innovation and interdisciplinary collaboration 🤝,  his continues to push the boundaries of medical technology. His work is shaping the future of healthcare solutions 🏥.

🌟 Professional Profile

🎓 Early Academic Pursuits

Yanmiao Ma embarked on a distinguished academic journey in Traditional Chinese Medicine (TCM), laying a strong foundation with a B.S. in Clinical Traditional Chinese Medicine from Shanxi College of Traditional Chinese Medicine (2002–2007).His further honed his expertise by earning an M.S. in Traditional Chinese Medicine from Shanxi Institute of Traditional Chinese Medicine (2007–2010).His pursuit of excellence culminated in a Ph.D. in Basic Medical Sciences from Hubei University of Chinese Medicine (2010–2013), where his focused on the mechanisms underlying TCM treatments for autoimmune diseases

💼 Professional Endeavors

Dr. Ma’s career is marked by significant academic and research contributions. His currently serves as an Associate Professor at the School of Basic Medical Sciences, Shanxi University of Chinese Medicine (2017–Present).His dedication to advancing biomedical research led his to a Visiting Scholar position at the School of Life Sciences, Shaanxi Normal University (2021–2022), specializing in Bioinformatics. Additionally,his participated in training programs under the Ministry of Education, focusing on English teaching for international students (2018). Previously,His contributed as a Lecturer at Shanxi University of Chinese Medicine (2013–2017).

🔬 Contributions and Research Focus On Molecular Biology 

Dr. Ma’s research spans multiple domains of rheumatology, immunology, gut microbiota, and cancer immunology.His work explores the mechanisms of TCM in treating rheumatoid arthritis (RA), particularly through immune regulation and synovial apoptosis, emphasizing the JAK-STAT/NF-κB signaling pathways.His is actively investigating the gut-joint axis in autoimmune diseases and pioneering fecal microbiota transplantation (FMT) for RA therapy.His contributions to cancer immunology focus on breast cancer stem cells, epithelial-mesenchymal transition (EMT), and lncRNA/miRNA regulatory networks, integrating TCM compounds such as icariin and ephedra polysaccharides into tumor microenvironment modulation.

🌍 Impact and Influence

Dr. Ma’s research has significantly advanced the understanding of TCM’s role in modern medicine.His studies on gut microbiota, autoimmune diseases, and cancer biology have influenced clinical applications and innovative therapeutic approaches.His has been at the forefront of developing multimodal studies, integrating TCM formulations with advanced biomedical research.His work has led to novel insights into microbial metabolites, immune modulation, and TCM-based drug delivery systems, fostering cross-disciplinary collaboration between traditional and modern medicine.

🏆 Awards and Honors

Dr. Ma has been the recipient of numerous prestigious research grants and awards, including:

  • Shanxi University of Chinese Medicine Basic-Clinical Collaboration Project (2024–2026)
  • Shanxi Provincial Science Foundation General Project (2024–2027)
  • Shanxi Health Commission TCM Innovation Team Leadership (2024–2027)
  • NSFC Youth Program for groundbreaking research on gut microbiota and rheumatoid arthritis (2022–2024)
    Her contributions have been acknowledged through his leadership in multiple high-impact projects, securing significant research funding.

📚 Academic Citations 

Dr. Ma has published extensively in high-impact journals, withHis research frequently cited in the fields of pharmacology, immunology, and biomedical sciences.His notable publications include studies on Ephedra sinica polysaccharides and rheumatoid arthritis, Icariin’s role in breast cancer EMT, and a scientometric analysis of kidney disease and gut microbiota.His research has received international recognition, positioning his as a leading figure in TCM-related biomedical studies.

📚Publications Top Notes

“Ephedra sinica polysaccharides regulate the anti-inflammatory immunity of intestinal microecology and bacterial metabolites in rheumatoid arthritis. Frontiers in Pharmacology”

“Icariin regulates EMT and stem cell-like character in breast cancer through modulating lncRNA NEAT1/TGFβ/SMAD2 signaling pathway.Biological and Pharmaceutical Bulletin”

“Pre​paration and biocompatibility of demineralized bone matrix/sodium alginate putty”

“Efficacy of Posterior Fossa Decompression with Duraplasty for Patients with Chiari Malformation Type I: A Systematic Review and Meta- Analysis“

 

Rui Wang | Molecular Biology | Best Researcher Award

Published on by Best Achievements

Mrs.  Rui Wang | Molecular Biology | Best Researcher Award

Mrs. Rui Wang, Beijing Children’s Hospital, China.

Rui Wang is a distinguished researcher specializing in environmental science and microbiology. With a Ph.D. in Environmental Engineering from the Chinese Academy of Sciences and a Master’s degree in Earth and Environmental Science from the University of Paul Cezanne, France, his academic journey is marked by excellence. His research focuses on antibiotics and heavy metals residue analysis, gut microbiota’s role in obesity, and antibiotic resistance genes. Dr. Wang has made significant contributions through projects addressing global challenges and has authored numerous impactful publications. His expertise in advanced analytical techniques further reinforces his role as a leader in his field.

Author Profile:

Scopus Profile

Summary of Suitability for Best Researcher Award:

Dr. Rui Wang  is highly suited for the Best Researcher Award due to his extensive and impactful research in environmental engineering, microbiology, and antibiotic resistance. His work, spanning multiple international projects, focuses on antibiotic and heavy metal residues in complex matrices and their effects on gut microbiota, with particular attention to obesity and antibiotic resistance. Rui’s diverse research experience includes leading projects funded by the National Natural Science Foundation of China and conducting influential studies on anaerobic digestion, wastewater treatment, and microbial community dynamics.

🎓 Education Background:

Dr. Rui Wang possesses an impressive educational background that forms the foundation of his research expertise. He earned his Ph.D. in Environmental Engineering from the prestigious Chinese Academy of Sciences, where his dissertation explored the effects of tetracyclines, copper, and their resistance genes on swine manure anaerobic digestion. Prior to this, he completed a Master’s degree in Earth and Environmental Science at the University of Paul Cezanne, France, focusing on arsenic uptake around rice roots in contaminated soils. Rui Wang began his academic journey with a Bachelor’s degree in Water Supply and Sewerage Engineering from Hebei University of Engineering, China.

💼 Professional Experience:

Dr. Rui Wang has extensive professional experience in environmental sciences and analytical chemistry. He served as a Postdoctoral Fellow in Biology at the Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, from 2015 to 2017. During this time, he conducted groundbreaking research on antibiotic resistance genes and their environmental impacts. Dr. Wang has also contributed significantly to water quality analysis through his role in projects such as the China-Sri Lanka Joint Center for Water Technology Research. Additionally, his expertise in advanced instrumentation, including HPLC-MS, ICP-MS, and GC-MS, has enabled him to develop innovative methods for analyzing complex environmental matrices.

🌍Research Contributions:

Dr. Rui Wang has made substantial contributions to environmental science, microbiology, and public health. His research addresses critical issues such as the analysis of antibiotic and heavy metal residues in complex matrices, the role of gut microbiota in obesity, and antibiotic resistance genes. Dr. Wang has led several impactful projects, including studies on the fate of antibiotics in swine manure anaerobic digestion and the effects of acetic acid on obesity-related intestinal microbes. His work on monitoring antibiotics in livestock and wastewater treatment systems has provided valuable insights into environmental health. With numerous publications, he continues to drive innovation in these fields.

🥇Award and Recognition

Dr. Rui Wang is a highly accomplished researcher whose work in environmental science and microbiology has made significant contributions to global health and environmental sustainability. Holding a Ph.D. in Environmental Engineering from the Chinese Academy of Sciences, his research focuses on critical areas such as antibiotics and heavy metals residue analysis, the gut microbiota’s role in obesity, and antibiotic resistance genes. With numerous impactful publications and international conference presentations, Dr. Wang’s expertise in advanced analytical techniques further solidifies his leadership in the field. His innovative approach and dedication to addressing pressing issues make him a deserving candidate for the Best Researcher Award.

Conclusion:

Dr. Rui Wang’s extensive academic background and pioneering research make him an ideal candidate for the Best Researcher Award. His work on antibiotics, heavy metals, and the gut microbiota’s role in obesity addresses pressing global health and environmental challenges. Dr. Wang’s leadership in innovative projects, combined with his proficiency in advanced analytical techniques, showcases his exceptional contributions to environmental science and microbiology. His numerous publications, international conference presentations, and commitment to advancing knowledge in his field demonstrate his lasting impact, making him a highly deserving candidate for this prestigious recognition.

📚Publication Top Notes

Simulating the multi-media fate of perfluorooctane sulfonate (PFOS) and its precursors in the Bohai coastal region of China

Year: 2024

Publication: Science of the Total Environment

🌊🔬

Vitamin D alleviates HFD-induced hepatic fibrosis by inhibiting DNMT1 to affect the TGFβ1/Smad3 pathway

Year: 2024

Publication: iScience

💊🧬

Generation of RAB4A homozygous knockout induced pluripotent stem cell (iPSC) line

Year: 2024

Publication: Stem Cell Research

🧫🔬

Emission estimation and health risk evaluation of aquaculture drugs commonly used in China

Year: 2024

Publication: Science of the Total Environment

Citations: 1

🐟💡

Imbalance of early-life vitamin D intake targets ROS-mediated crosstalk between mitochondrial dysfunction and differentiation potential of MSCs associated with later obesity

Year: 2024

Publication: Stem Cell Research and Therapy

Citations: 1

🧬💪

Interactions and Conflicts between Urbanization and Greenness: A Case Study from Nanjing, China

Year: 2024

Publication: Remote Sensing

🏙️🌳

Decreased vitamin D bio-availability with altered DNA methylation of its metabolism genes in association with the metabolic disorders among school-aged children with degree I, II, and III obesity

Year: 2024

Publication: Journal of Nutritional Biochemistry

🧬🍽️

Simulating behavior of perfluorooctane sulfonate (PFOS) in the mainstream of a river system with sluice regulations

Year: 2024

Publication: Chemosphere

Citations: 1

🌊⚙️

Paternal preconceptional supplementation of n-3 polyunsaturated fatty acids alleviates offspring nonalcoholic fatty liver disease in high-fat diet-induced obese mice

Year: 2024

Publication: Food Frontiers🍔💊

Biomagnification and health risks of perfluoroalkyl acids (PFAAs) in seafood from the Yangtze river estuary of China

Year: 2024

Publication: Environmental Pollution

🦑💧